IBio Number of Employees 2010-2024 | IBIO

IBio number of employees from 2010 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

IBio Number of Employees 2010-2024 | IBIO

IBio number of employees from 2010 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$162B
Vertex Pharmaceuticals (VRTX)$127.4B
Bristol Myers Squibb (BMY)$118.5B
Gilead Sciences (GILD)$115.4B
CSL (CSLLY)$90B
Regeneron Pharmaceuticals (REGN)$88.4B
GSK (GSK)$72.8B
Argenex SE (ARGX)$35.8B
Alnylam Pharmaceuticals (ALNY)$34.1B
BioNTech SE (BNTX)$26.7B
Biogen (BIIB)$24.2B
Illumina (ILMN)$23.2B
BeiGene (BGNE)$19B
Moderna (MRNA)$16.2B
Incyte (INCY)$15.5B
Genmab (GMAB)$14.3B
BioMarin Pharmaceutical (BMRN)$12.7B
Insmed (INSM)$12.6B
Bio-Techne Corp (TECH)$12.1B
Vaxcyte (PCVX)$12B
Sarepta Therapeutics (SRPT)$10.7B
Exelixis (EXEL)$10B
Revolution Medicines (RVMD)$9.8B
QIAGEN (QGEN)$9.7B
Exact Sciences (EXAS)$9.4B
Bio-Rad Laboratories (BIO.B)$9.4B
Intra-Cellular Therapies (ITCI)$9.4B
Roivant Sciences (ROIV)$8.8B
Repligen (RGEN)$8.4B
Ascendis Pharma (ASND)$7.6B